The aim of this project is to evaluate the needs and provision of care for patients in the late stages of Parkinsonism and their carers in several European countries, to compare the effectiveness of different health and social care systems, and to lay the foundation for improved outcomes in this population. The investigators will undertake an in-depth assessment of patients and their care arrangements in a population recruited through networks in six European countries. The systems and procedures that are used in the provision of care will be reviewed through a systematic literature review, interviews and assessments of patients, carers and health care providers, and through a trial comparing assessment by a specialist with management suggestions, guidance and access to telephone advice to that of usual care. Through interviews, questionnaire assessment and review of current health-care and social care arrangement, the investigators will assess the needs, provision of care and use of health-care resources, and their impact on patient and carer outcomes in different countries. National and regional databases will also be interrogated to identify current practice and use of healthcare resources and drug usage. A systematic literature review of the evidence for effective management strategies, analysis of the study data, and evaluation of change in outcomes following specialist review will provide the basis for recommendations in the management of late stage Parkinsonism. The investigators will also evaluate potentially useful outcome measures for use in this patient group. In addition to charting the needs and current care provision for late stage Parkinsonism in different European countries, its cost and effectiveness, and an analysis of health-care and social care predictors of improved outcome, the project will produce a platform for the assessment of patients with late stage Parkinsonism, their current treatment and care provision, as well as guidelines on the management of this late disease phase.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
184
Specialist review with individually tailored treatment strategies suggested by specialist
University of Bordeaux
Bordeaux, France
University of Munich
Munich, Bavaria, Germany
University of Marburg
Marburg, Germany
Radboud university medical center
Nijmegen, Netherlands
Instituto de Medicina Molecular
Lisbon, Portugal
Lund University
Lund, Sweden
University College London
London, United Kingdom
UPDRS-ADL part
Disability measure
Time frame: 6 months
PDQ-8 or DEMQoL proxy
Quality of Life
Time frame: 6 months
Zarit carer burden scale
Carer burden
Time frame: 6 months
Satisfaction with care Likert scale
Time frame: 6 months
MMSE
Mental health
Time frame: 6 months
NPI
Mental health
Time frame: 6 months
UPDRS III
PD severity
Time frame: 6 months
NMSS
PD severity
Time frame: 6 months
PD milestones
PD severity
Time frame: 6 months
Basic palliative care assessment
ESAS-PD
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.